Westlake Chemical Comments on Georgia Gulf's Rejection of Its All Cash Proposal
1/17/2012 8:40:08 AM
"Georgia Gulf's Board is once again standing in the way of its shareholders receiving immediate value and a substantial premium. Georgia Gulf's rejection of our proposal and their adoption of a "poison pill" is entirely consistent with its Board's entrenched approach and refusal to come to the table to negotiate in good faith.
"We have made a fair and compelling proposal that offers superior value
to
"Last night's response from
About
Forward Looking Statements
Except for the historical information contained herein, the matters
discussed in this press release are forward-looking statements that
involve certain risks and uncertainties. These risks and uncertainties
relate to, among other things, (i) successfully completing the proposed
transaction or realize the anticipated benefits of a transaction;
(ii) obtaining Georgia Gulf stockholder and other approvals for the
proposed transaction on the terms proposed and in a timely manner;
(iii) achieving our expected financial performance following completion
of the proposed transaction; and (iv) the risks and uncertainties
inherent in the petrochemicals, polymers and building products
industries discussed in our filings with the
Additional Information
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of any
vote, proxy or approval. No tender offer for the shares of Georgia Gulf
has been made at this time. This press release relates to a potential
business combination transaction with Georgia Gulf proposed by Westlake.
This material is not a substitute for any tender offer statement, proxy
statement or any other document which Westlake may file with the
Westlake, the directors and executive officers of Westlake, and other
persons may be deemed to be participants in any future solicitation of
proxies from Georgia Gulf shareholders in respect of the proposed
transaction with Georgia Gulf. Information regarding Westlake's
directors and executive officers is available in Westlake's Annual
Report on Form 10-K for the year ended
Source:
Media Inquiries:
Westlake Chemical Corp.
David R.
Hansen, 713-960-9111
or
Sard Verbinnen & Co
Jim
Barron, 212-687-8080
jbarron@sardverb.com
Robin
Weinberg, 212-687-8080
weinberg@sardverb.com
or
Investor
Inquiries:
Westlake Chemical Corp.
Steve Bender,
713-585-2643
or
MacKenzie Partners
Dan Burch, 800-322-2885
dburch@mackenziepartners.com
Charlie
Koons, 800-322-2885
ckoons@mackenziepartners.com

